Revixia is one of the few companies seeking to develop Salvinorin A for a host of mental disorders. The main benefit noted by Revixia is the shorter duration of salvia (SalA) in comparison to other psychedelics.
The company is a subsidiary of atai Life Sciences.
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates